Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Colorcon
Chinese Patent Office
Fish and Richardson
Farmers Insurance
Harvard Business School
Moodys
Cipla

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018760

« Back to Dashboard

NDA 018760 describes TENORETIC 50, which is a drug marketed by Alvogen Malta and is included in one NDA. It is available from two suppliers. Additional details are available on the TENORETIC 50 profile page.

The generic ingredient in TENORETIC 50 is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 018760
Tradename:TENORETIC 50
Applicant:Alvogen Malta
Ingredient:atenolol; chlorthalidone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018760
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectIncreased Diuresis
Suppliers and Packaging for NDA: 018760
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760 NDA AstraZeneca Pharmaceuticals LP 0310-0115 N 0310-0115-10
TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760 NDA AstraZeneca Pharmaceuticals LP 0310-0117 N 0310-0117-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG;25MG
Approval Date:Jun 8, 1984TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG;25MG
Approval Date:Jun 8, 1984TE:ABRLD:Yes

Expired US Patents for NDA 018760

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Colorcon
Julphar
Mallinckrodt
Citi
Daiichi Sankyo
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.